Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
Condition: Esophageal Cancer Interventions: Drug: Lerotinib; Drug: Irinotecan/Tegafur Sponsor: Sunshine Lake Pharma Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials